Novartis Pharmaceuticals Cambridge , MA 02138
The Cardiovascular & Metabolic Disease Group at the Novartis Institutes for Biomedical Research is committed to discovering innovative treatments for cardiovascular and metabolic disorders. We are seeking an experienced research scientist with expertise in renal physiology and/or renal diseases, to join the team.
The successful candidate will be responsible for leading a laboratory of PhD and BS/MS level scientists to design and develop novel therapies for common renal diseases. In addition, the candidate will help to define and drive the scientific strategy for novel renal therapies at NIBR. Experience in drug discovery and development would be an advantage.
Along with the ability to innovate, excellent communication and analytical skills are required. The specific requirements for the position are:
An excellent track record of scientific achievement
Expertise in renal physiology and/or renal diseases
Experience with animal models of genetic and/or acquired renal diseases
Strong command of scientific literature, and have relationships with key opinion leaders in academia and industry in the therapeutic area EEO Statement The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Minimum requirements PhD and/or MD with postdoctoral experience and a minimum of five years of research in physiology, pharmacology or closely related discipline. The successful candidate will be an innovative scientist who is results-oriented and able to excel in a fast-track environment. He or she will be a strategic thinker who interacts and collaborates with peers and management in identifying and achieving discovery goals from both scientific and strategic perspectives.